Akari Therapeutics PLC
F:CLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Akari Therapeutics PLC
F:CLA
|
US |
|
S
|
Saul Centers Inc
F:SA4
|
US |
Shareholder Yield
Current shareholder yield for
CLA is
.
Peers Comparison
Shareholder Yield
Price Appreciation
CLA Price
Akari Therapeutics PLC
| Average Annual Return | -50.69% |
| Standard Deviation of Annual Returns | 28.8% |
| Max Drawdown | -100% |
| Market Capitalization | 18.8m EUR |
| Shares Outstanding | 3 573 970 000 |
| Percentage of Shares Shorted |
N/A
|
CLA Return Decomposition
Main factors of price return
Stock Splits
CLA's latest stock split occurred on Mar 31, 2026
The company executed a 1-for-40 stock split, meaning that for every 40 shares held, investors received 1 new share.
Before the split, CLA traded at 2.44 per share. Afterward, the share price was about 0.0556.
The adjusted shares began trading on Mar 31, 2026. This was stock split number 2 in CLA's history, following the previous one in Aug 17, 2023.